These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 13984520)

  • 21. ENZYMIC OXIDATION OF METHOTREXATE AND AMINOPTERIN.
    JOHNS DG; IANNOTTI AT; SARTORELLI AC; BOOTH BA; BERTINO JR
    Life Sci (1962); 1964 Dec; 3():1383-8. PubMed ID: 14248626
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhibition of dihydrofolic reductase by aminopterin and amethopterin.
    OSBORN MJ; FREEMAN M; HUENNEKENS FM
    Proc Soc Exp Biol Med; 1958 Feb; 97(2):429-31. PubMed ID: 13518295
    [No Abstract]   [Full Text] [Related]  

  • 23. Reversal of aminopterin and amethopterin toxicity by citrovorum factor.
    SCHOENBACH EB; GREENSPAN EM; COLSKY J
    J Am Med Assoc; 1950 Dec; 144(18):1558-60. PubMed ID: 14794378
    [No Abstract]   [Full Text] [Related]  

  • 24. [PSORIASIS AND AMINOPTERIN].
    VILANOVA X; DEMORAGAS JM
    Actas Dermosifiliogr; 1963 May; 54():147-54. PubMed ID: 14078704
    [No Abstract]   [Full Text] [Related]  

  • 25. A GROWING SPECTRUM FOR THE ANTIMETABOLITES.
    HART GD
    Appl Ther; 1964 Jul; 6():596-8. PubMed ID: 14179437
    [No Abstract]   [Full Text] [Related]  

  • 26. Psoriasis--chemotherapy with aminopterin and methotrexate.
    REES RB; BENNETT JH
    Skin (Los Angeles); 1962 Dec; 1():381-2. PubMed ID: 13973589
    [No Abstract]   [Full Text] [Related]  

  • 27. Developmental delay in fetal aminopterin/methotrexate syndrome.
    Del Campo M; Kosaki K; Bennett FC; Jones KL
    Teratology; 1999 Jul; 60(1):10-2. PubMed ID: 10413333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Folic-acid antagonists in psoriasis.
    Br Med J; 1966 May; 1(5499):1313. PubMed ID: 5934371
    [No Abstract]   [Full Text] [Related]  

  • 29. Differing specificities for 4-aminofolate analogues of folylpolyglutamyl synthetase from tumors and proliferative intestinal epithelium of the mouse with significance for selective antitumor action.
    Rumberger BG; Barrueco JR; Sirotnak FM
    Cancer Res; 1990 Aug; 50(15):4639-43. PubMed ID: 2369741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FURTHER OBSERVATIONS OF THE BINDING AND INHIBITION OF DIHYDROFOLIC REDUCTASE BY FOLIC ACID ANTAGONISTS.
    SCHRECKER AW; HUENNEKENS FM
    Biochem Pharmacol; 1964 May; 13():731-42. PubMed ID: 14181276
    [No Abstract]   [Full Text] [Related]  

  • 31. [CYTOSTATIC DRUGS IN THE TREATMENT OF PSORIASIS. WITH SPECIAL REFERENCE TO THE ORAL USE OF AMINOPTERIN].
    WEREIDE K
    Tidsskr Nor Laegeforen; 1964 Oct; 84():1323-7. PubMed ID: 14230476
    [No Abstract]   [Full Text] [Related]  

  • 32. SOME EFFECTS OF FOLIC ACID ANTAGONISTS ON VIRUS INDUCED CHICKEN ERYTHROLEUKAEMIA.
    STENKVIST B; PONTEN J
    Acta Pathol Microbiol Scand; 1964; 61():46-54. PubMed ID: 14150633
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical potency of methotrexate, aminopterin, talotrexin and pemetrexed in childhood leukemias.
    Norris RE; Adamson PC
    Cancer Chemother Pharmacol; 2010 May; 65(6):1125-30. PubMed ID: 19784838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of dihydrofolate reductase from bacterial and vertebrate sources by folate, aminopterin, methotrexate and their 5-deaza analogues.
    Stone SR; Montgomery JA; Morrison JF
    Biochem Pharmacol; 1984 Jan; 33(2):175-9. PubMed ID: 6367748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Psoriasis. treatment by aminopterin and methotrexate].
    RAVINA A
    Annee Ther; 1962; 33():44-6. PubMed ID: 13990834
    [No Abstract]   [Full Text] [Related]  

  • 36. Syntheses and antifolate activity of 5-methyl-5-deaza analogues of aminopterin, methotrexate, folic acid, and N10-methylfolic acid.
    Piper JR; McCaleb GS; Montgomery JA; Kisliuk RL; Gaumont Y; Sirotnak FM
    J Med Chem; 1986 Jun; 29(6):1080-7. PubMed ID: 2423690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of folate antagonists on the metabolism of folic acid and its reduced derivatives in rat liver and kidney.
    Bühring U; Shin YS; Fölsch E
    Cancer Res; 1977 Jan; 37(1):299-304. PubMed ID: 830415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CLINICAL STUDIES OF DICHLOROMETHOTREXATE (NSC 29630).
    FREI E; SPURR CL; BRINDLEY CO; SELAWRY O; HOLLAND JF; RALL DP; WASSERMAN LR; HOOGSTRATEN B; SHNIDER BI; MCINTYRE OR; MATTHEWS LB; MILLER SP
    Clin Pharmacol Ther; 1965; 6():160-71. PubMed ID: 14288185
    [No Abstract]   [Full Text] [Related]  

  • 39. Chromosomal abnormalities produced by folic acid antagonists.
    Ryan TJ; Boddington MM; Spriggs AI
    Br J Dermatol; 1965 Nov; 77(11):541-55. PubMed ID: 5853249
    [No Abstract]   [Full Text] [Related]  

  • 40. New folate analogs of the 10-deaza-aminopterin series: markedly increased antitumor activity of the 10-ethyl analog compared to the parent compound and methotrexate against some human tumor xenografts in nude mice.
    Schmid FA; Sirotnak FM; Otter GM; DeGraw JI
    Cancer Treat Rep; 1985 May; 69(5):551-3. PubMed ID: 4005878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.